Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
0
Authors
Pravesh Gupta
Pravesh Gupta•Minghao Dang•Krishna Bhat
Published
August 8, 2024
Abstract
Human gliomas are classified using isocitrate dehydrogenase (IDH) status as a prognosticator; however, the influence of genetic differences and treatment effects on ensuing immunity remains unclear.
